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miRNAs can function as both tumour suppressors and oncogenes, which depend on the biological function of their target genes. 9, 10 For instance, miR-506-3p functions as a tumour suppressor by suppressing the proliferation and metastasis of OS cells via targeting RAB3D. 11 MiR-613 inhibits OS cell proliferation and migration, and induces apoptosis by targeting chemokine receptor 4 (CXCR4). 12 While, our previous study reports that miR-92a is overexpressed in OS tissues and facilitates tumour growth of OS via suppressing phosphatase and tensin homologue (PTEN) and AKT signalling pathway. 13 Recently, A new tumour-suppressive miR-876-5p has been found to play important roles in a variety of tumours including lung cancer, 14 oesophageal squamous cell carcinoma (ESCC), 15 hepatocellular carcinoma (HCC) 16, 17 and head and neck squamous cell carcinoma (HNSCC). 18 MiR-876-5p inhibits the epithelial-mesenchymal transition (EMT) and tumour metastasis in lung cancer, HCC and HNSCC. 14, 16, 18 Moreover, miR-876-5p suppresses tumour growth and metastasis of ESCC by targeting tumour antigen MAGE-A family. 15 However, the biological function and potential molecular mechanisms of miR-876-5p in human OS are unclear.
In this study, we first determined the expression of miR-876-5p
between OS and matched para-cancerous tissues. Then, the clinical significance, biological functions and related molecular mechanisms of miR-876-5p were investigated. In conclusion, our results suggest that miR-876-5p may be an effective therapeutic target for OS patients.
| MATERIAL S AND ME THODS

| Clinical specimens
Sixty-eight OS tissues and matched para-cancerous tissues were collected from Renji Hospital, School of Medicine, Shanghai Jiaotong University. None of the OS patients received chemotherapy or radiotherapy before surgery. The collected specimens were obtained with the informed consent of the patients or the patient's families.
The collected OS tissue and para-cancerous tissues were stored immediately in liquid nitrogen for subsequent analysis. The protocols and consents were approved by the Ethics Committee of Shanghai Jiaotong University and complied with the Declaration of Helsinki.
| Cell culture and transfection
The human OS cell lines U2OS and MG63 were saved in our laboratory. 13 OS cells were cultured in DMEM medium (Hyclone, Logan, UT) containing 10% Fetal bovine serum (FBS, Gibco, Grand Island, NY), streptomycin (100 µg/mL; Sigma-Aldrich, St. Louis, MO) and penicillin (100 U/mL, Sigma-Aldrich) at 37°C in a humidified atmosphere comprising 5% CO 2 .
Lentiviral vector-mediated precursor miR-876-5p and negative control were obtained from Sigma-Aldrich Co. LLC. MiR-876-5p inhibitors in lentiviral vectors and control inhibitors were purchased from Geneopenia (Guangzhou, China). OS cells were infected with lentiviruses in the presence of Polybrene (8 ng/mL, Sigma-Aldrich).
After overnight incubation, the virion-containing culture supernatant was removed and replaced with fresh virus-free medium. 
| Cell proliferation analysis
The 5-ethynyl-2'-deoxyuridine (EdU) proliferation assay was used to measure cell proliferation. We added 0. 
| Cell migration and invasion assay
The migration and invasion ability of U2OS and MG63 cells were assessed using 6.5-mm transwell chambers with a pore size of 8 μm 
| Western blotting analysis
Total cellular protein was extracted using Radio-Immunoprecipitation 
| Tumour xenograft assay
| Target identification and dual luciferase assay
To identify the target, miR-876-5p was subjected to the online platform starBase V3.0. 20 For the luciferase reporter assay, the binding
The expression and prognostic significance of miR-876-5p in osteosarcoma (OS). A, The relative level of miR-876-5p in 68 pairs of OS and matched para-cancerous tissues was quantified by quantitative real-time PCR P = 0.0009 by t test. B, OS patients were divided into two subgroups (low/high miR-876-5p level, n = 34 per group) using the median level of miR-876-5p as a cut-off value. Low miR-876-5p level in OS tissues predicted poor prognosis of OS patients. P = 0.0108 by log-rank test sites of the wild-type (wt) and the mutated (mt) c-Met 3′-UTR were cloned into the downstream region of the luciferase gene in the PGL3-REPORT luciferase vector (Invitrogen). The HEK293T cells were then subjected to cotransfection with the wt or mt PGL3-c-Met-3′UTR vectors and precursor miR-876-5p or miR-876-5p inhibitors. Finally, the luciferase activity was determined using a Luciferase Reporter Assay kit (Promega Corporation, Madison, WI) as per the manufacturer's protocol, and Renilla luciferase activity was used to normalize the data.
| Statistical analysis
All data in the experiments were analysed statistically using GraphPad Prism 6.0 Software (GraphPad Inc, San Diego, CA). All experiments were repeated at least three times and the data were expressed as mean ± SD. Survival curves were evaluated using the Kaplan-Meier method and
differences between survival curves were tested by the log-rank test. P < 0.05 was considered statistically significant.
| RE SULTS
| miR-876-5p is down-regulated in OS tissues
In order to investigate the clinical significance of miR-876-5p in OS, we detected the expression of miR-876-5p using quantitative real-time PCR (qRT-PCR). As shown in Figure 1A , the expression levels of miR-876-5p were detected in 68 pairs of OS and matched para-cancerous tissues. The results revealed that miR-876-5p expression was significantly down-regulated in OS tissue samples compared to para-cancerous tissues (P = 0.0009, Figure 1A ). OS patients were divided into two subgroups (low/high miR-876-5p level) using the median level of miR-876-5p as a cut-off value. As shown in Table 1 , the low expression of miR-876-5p was positively correlated with advanced clinical stage (P = 0.026) and poor differentiation (P = 0.006). Moreover, OS patients with low miR-876-5p
level had a significant shorter overall survival compared to cases F I G U R E 2 miR-876-5p restoration inhibits the proliferation, migration and invasion of osteosarcoma (OS) cells. A, U2OS and MG63 cells that were transfected with lentivirus-mediated scrambled control or precursor miR-876-5p were detected by qRT-PCR for miR-876-5p expression. n = three independent repeats, *P < 0.05 by t test. B, Cell Counting Kit-8 assay investigated that miR-876-5p overexpression inhibited the viability of OS cells. n = three independent repeats, *P < 0.05 by ANOVA. C, 5-ethynyl-2'-deoxyuridine (EdU) assay revealed that miR-876-5p restoration suppressed the proliferation of OS cells. Scale bar: 20 μm, n = three independent repeats, *P < 0.05 by t test.
(D,E) Transwell assay indicated that the migration and invasion ability of cells were restrained by miR-876-5p overexpression in both U2OS and MG63 cells. n = three independent repeats, *P < 0.05 by t test with high miR-876-5p level (P = 0.0108, Figure 1B) . Thus, miR-876-5p expression may be a promising prognostic marker for OS patients.
| miR-876-5p inhibits OS cell proliferation, migration and invasion
Furthermore, to investigate the functional role of miR-876-5p in OS cells, we used lentiviruses to establish miR-876-5p stably highexpressing U2OS and MG63 cells (P < 0.05, Figure 2A ). The CCK8
and EdU assays showed that miR-876-5p restoration inhibited the proliferation of OS cells (P < 0.05, Figure 2B ,C). Furthermore, the migrated and invaded cells were prominently reduced after miR-876-5p overexpression in both U2OS and MG63 cells (P < 0.05, Figure 2D ,E). Next, the expression of miR-876-5p was knocked down by lentivirus-mediated miR-876-5p inhibitors in U2OS and MG63 cells and the knockdown efficiency was verified by qRT-PCR after 72 hours infection (P < 0.05, Figure 3A) . Conversely, miR-876-5p knockdown significantly promoted the proliferation, migration and invasion of OS cells in vitro (P < 0.05, Figure 3B-D) . These data suggest that miR-876-5p plays a tumour-suppressive role in OS.
| miR-876-5p suppresses the growth of MG63 cells in mice
To further confirm the effects of miR-876-5p on the proliferation of OS cells in vivo, we established a subcutaneous tumour formation model in nude mice. MG63 cells that were transfected with scrambled control or precursor miR-876-5p were subcutaneously injected into the right flank of mice. Thirty days after implantation, the tumour growth curves showed that ectopic expression of miR-876-5p
significantly inhibited the tumour growth of OS in mice (P < 0.05, Figure 4A ), and reduced the tumour weight (P < 0.05, Figure 4B ).
The high expression of miR-876-5p in tumour tissues was confirmed in miR-876-5p overexpression group compared to control group (P < 0.05, Figure 4C ). Moreover, IHC analysis of the tumour tissues indicated that the percentage of Ki-67 positive tumour cells in miR-876-5p overexpression group was markedly lower than that in control group (P < 0.05, Figure 4D ).
F I G U R E 3 miR-876-5p knockdown promotes osteosarcoma (OS) cell proliferation, migration and invasion. A, U2OS and MG63 cells that
were transfected with lentivirus-mediated control inhibitors or miR-876-5p inhibitors were detected by qRT-PCR for miR-876-5p expression. n = three independent repeats, *P < 0.05 by t test. B, Cell Counting Kit-8 assay investigated that miR-876-5p knockdown promoted the viability of OS cells. n = three independent repeats, *P < 0.05 by ANOVA. C, 5-ethynyl-2'-deoxyuridine (EdU) assay revealed that miR-876-5p knockdown facilitated the proliferation of OS cells. Scale bar: 20 μm, n = three independent repeats, *P < 0.05 by t test. (D,E) Transwell assay indicated that the migration and invasion ability of cells were enhanced by miR-876-5p knockdown in both U2OS and MG63 cells. n = three independent repeats, *P < 0.05 by test
| c-Met is a target gene of miR-876-5p in OS cells
To disclose the underlying mechanism involved the tumour-suppressive role of miR-876-5p in OS, potential targets of miR-876-5p were predicted by starBase V3.0 online platform. c-Met, a well-known oncogene in OS, caught our attention. Then, dual luciferase reporter assay indicated that miR-876-5p overexpression significantly reduced while miR-876-5p knockdown prominently increased luciferase intensity of vector carrying wt c-Met 3′UTR in HEK293T cells (P < 0.05, Figure 5B ). While, modulating miR-876-5p level did not alter luciferase intensity of vector carrying mt c-Met 3′UTR ( Figure 5B ).
Furthermore, miR-876-5p restoration significantly reduced while miR-876-5p knockdown increased the level of c-Met protein in both U2OS and MG63 cells (P < 0.05, Figure 5C ). The expression of c-Met protein in xenograft tissues from miR-876-5p overexpression group was significantly lower than that in control group (P < 0.05, Figure   S1A ). Quantitative real-time PCR analysis indicated that the expression of c-Met mRNA in OS tissues was obviously higher than that in para-cancerous tissues (P < 0.0001, Figure 5D ). Notably, an inverse correlation between miR-876-5p and c-Met expression was confirmed in OS tissues (r = −0.5956, P < 0.0001, Figure 5E ). The level of c-Met protein in OS tissues with high miR-876-5p expression was obviously lower than that in miR-876-5p low-expressing OS tissues (P < 0.05, Figure S1B ). These data suggest that miR-876-5p directly binds to the 3′UTR of c-Met to repress its expression.
| c-Met participates in the tumour-suppressive role of miR-876-5p in OS cells
To study whether c-Met was a downstream effector of miR-876-5p
in OS cells, the expression of c-Met was resorted via plasmid transfection in miR-876-5p overexpressing U2OS cells and confirmed by immunoblotting (P < 0.05, Figure 6A ). As shown in Figure 6B Photograph of tumours derived from both miR-876-5p overexpression group (n = 6) and control group (n = 6). Right: Tumour growth curves indicated that U2OS cells with miR-876-5p overexpression grew significantly slower than control cells in mice. Scale bar: 1 cm. *P < 0.05 by ANOVA. B, miR-876-5p overexpression significantly reduced tumour weight in experimental group (n = 6) compared to control group (n = 6). *P < 0.05 by t test. C, High miR-876-5p level was detected in tumour tissues from experimental group (n = 6) compared to that in control group (n = 6). *P < 0.05 by t test. D, Immunohistochemical staining of Ki-67 showed that miR-876-5p overexpression inhibited the proliferation of MG63 cells in vivo. Scale bar: 50 μm. n = 6, *P < 0.05 by t test S1A-E). These results demonstrate that miR-876-5p inhibits the proliferation, migration and invasion of OS cells through repression of c-Met.
| D ISCUSS I ON
Accumulating evidence have revealed that miRNAs regulate many oncogenes and tumour suppressors in cells, and lead to initiation and progression of cancer. 21 Recent years, several miRNAs have been identified as key regulators of OS progression and excellent predictors for clinical outcome of OS patients 22, 23 Decreased expression of miR-876-5p has been observed in HNSCC, HCC, ESCC and lung cancer. 14, 15 Moreover, miR-876-5p underexpression is associated with poor prognostic features and reduced survival of HCC patients. 16 In the present study, we investigated the expression of miR-876-5p and its clinical significance in OS. Quantitative real-time PCR data showed that miR-876-5p expression was decreased in OS tissues compared with para-cancerous tissues. Clinical data analysis revealed that OS tissues with advanced clinical stage and poor differentiation had an obvious lower expression of miR-876-5p. Moreover, low miR-876-5p
level predicted poor prognosis of OS patients. These data indicate that miR-876-5p may be used as a potential biomarker for diagnosis and prognosis of HCC.
F I G U R E 5 miR-876-5p inversely regulates c-Met expression via posttranscriptional modulation. A, The complementary binding sequences of miR-876-5p in wild-type (wt) 3′UTR of c-Met. Mutated (mt) 3′UTR of c-Met was generated to disturb the binding between miR-876-5p and c-Met. B, miR-876-5p overexpression obviously inhibited whereas miR-876-5p knockdown significantly increased the luciferase activity that carried wt but not mt 3′UTR of c-Met. n = three independent repeats, *P < 0.05 by t test. C, miR-876-5p overexpression obviously reduced whereas miR-876-5p knockdown significantly increased c-Met abundance in both U2OS and MG63 cells. n = three independent repeats, *P < 0.05 by t test. D, The expression of c-Met mRNA in OS tissues was significantly higher than that in matched para-cancerous tissues. n = three independent repeats, *P < 0.05 by t test. E, miR-876-5p expression was negatively correlated with c-Met mRNA level in OS tissues. n = 68, *P < 0.05 by Pearson correlation test
The tumour-suppressive role of miR-876-5p has been reported in HNSCC, HCC, ESCC and lung cancer. 
| CON CLUS IONS
To conclude, we investigated the expression of miR-876-5p between OS and matched para-cancerous tissues, and elucidated the functional role of miR-876-5p and its underlying molecular mechanisms in OS 
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